Rapid, accurate, low-cost blood test to help diagnose concussion
Official title: RACE Study: Rapid, Accurate and Cost-effective Analysis of Glial Fibrillary Acid Protein Using a Hand-held Biosensor for Patient With Concussion in Acute Care and at Home Monitoring
Run by University of Calgary · NCT05588115 · Data updated 2026-11-12
This study will test if a portable biosensor can accurately measure a blood biomarker (GFAP) to help diagnose concussion in adults who come to the emergency department.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 225 (estimated) |
| Sponsor | University of Calgary Academic / other |
| Locations | 1 site (Calgary, Alberta) |
| Status | Recruiting |
| Started | December 1, 2022 |
| Main results expected | April 30, 2025 |
| Study ends | December 2027 |
| Registry record updated | February 5, 2026 |
| Trial ID | NCT05588115 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–65 with a recent (within 7 days) uncomplicated concussion presenting to the emergency department, or adults 18–65 with a musculoskeletal injury for the comparison group.
✕Probably not a fit
People with complicated mild TBI (positive neuroimaging), a history of moderate/severe TBI, preexisting neurological or major metabolic disease, or those more than 7 days from injury are not likely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will enroll adults (18–65) with uncomplicated concussion and a comparison group with musculoskeletal injury, collecting blood at the initial visit and at 2, 6, and 12 weeks plus brief questionnaires and daily symptom check-ins. Researchers will compare biomarker levels measured by the biosensor to the current laboratory gold-standard assay to determine agreement and accuracy. They will also analyze whether biosensor measurements relate to patients' physical and psychological symptoms over time. The concussion group will be compared to the musculoskeletal group to test whether biosensor signals are specific to brain injury.
Why it matters
Potential benefit: If successful, the biosensor could enable faster, cheaper bedside blood testing to support concussion diagnosis and track recovery.
How similar studies have gone: Prior research supports GFAP as a useful blood biomarker for brain injury, but using a portable biosensor for rapid, low-cost measurement is an emerging approach that is only partially validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (concussion group): 1. diagnosed with an uncomplicated concussion according to the ICD-10 criteria with no intracranial abnormalities 2. between the ages of 18-65 years old. Inclusion Criteria (MSK group): 1. diagnosed with any form of musculoskeletal injury in absence of comorbidities 2. between the ages of 18-65 years old Exclusion Criteria: 1. complicated mild TBI (positive neuroimaging findings) 2. current or history of moderate or severe traumatic brain injury 3. history of neurological issue(s) (stroke, seizures, dementia, Alzheimer's, etc.) or metabolic disease(s) (diabetes, liver disease, kidney disease, cardiovascular disease, etc.) 4. greater than 7 days from injury at initial visit
Where it's running
-
Foothills Medical Centre
Calgary, Alberta, Canada Recruiting
Study contacts
- Principal investigator: Chantel T Debert, MD, MSc — University of Calgary
- Study coordinator: Chantel T Debert, MD, MSc
- Email: cdebert@ucalgary.ca
- Phone: 4039444500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tinted daily contact lenses for light sensitivity after a concussion
This project will try daily disposable tinted contact lenses to reduce light sensitivity in adults who have had a mild concussion.
-
Cooling therapy for mild traumatic brain injury in adolescents
This study is testing if a cooling device can help young athletes aged 12-21 recover better from mild brain injuries they got while playing sports.
-
Combining Acceptance and Commitment Therapy with Vestibular Rehabilitation for mTBI
This study is testing if combining a therapy that helps with acceptance and commitment with standard balance exercises can better help military service members with mild traumatic brain injury and related symptoms feel better.
-
Automated virtual reality therapy for eye recovery after brain injury
This study tests a new virtual reality therapy to see if it can help veterans with vision problems after a brain injury feel better.
-
Improving access to specialty care for concussion patients
This study is testing a new mobile health program to help concussion patients get better care faster and improve their recovery by allowing them to share their symptoms daily with doctors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.